27 September 2021
24 September 2021
23 September 2021
23 August 2021
27 July 2021
At the 2021 Toxicology Forum Virtual Summer Meeting Dr. David Ponting, Lhasa Senior Scientist will be chairing a session on Monday 2nd August titled, N-Nitrosamine Impurities in Pharmaceuticals - Potency, Prediction, and Acceptable Limits.
15 July 2021
14 July 2021
In this virtual event we investigated the new ANVISA guidance for N-Nitrosamines with presentations from ANVISA, Industry - GSK and Libbs Farmacêutica - and Lhasa representatives.
2021 Webinar | Accessing vital sources of long-term carcinogenicity study data with Lhasa’s Carcinogenicity Database – An update and an overview
07 July 2021
2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab
24 June 2021
We were delighted to welcome Andrew Teasdale PhD to present within this webinar; Why you should consider controlling your potentially mutagenic impurities outside the lab.
Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity areas, including mutagenic impurities (MIs).
07 June 2021